Clinical trial · Observational

The Role of C1q Tumor Necrosis Factor-related Protein 6 in Breast Cancer

The Role of C1q Tumor Necrosis Factor-related Protein 6 (CTRP6) in Breast Cancer

NCT04611308CI-TRIAL-00048039unknownClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

Globally, breast cancer is one of the most prevalent cancers in women and is the second leading cause of cancer death , representing 15% of worldwide deaths per year . In Egypt, it accounts for 32 % of cancer in women with a high mortality rate.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Breast Cancer	Malignant Breast Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
C1q tumor necrosis factor-related protein 6 levels	Other	—	UNRESOLVED

Design

Arms and outcomes

Arms (2)

label
cases
interventionNames
1. Other: C1q tumor necrosis factor-related protein 6 levels
label
controls
interventionNames
1. Other: C1q tumor necrosis factor-related protein 6 levels

Primary outcomes (1)

measure
To investigate the CTRP6 levels in breast cancer.
timeFrame
1 October 2021

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

* Age: 18 years and older.
* Newly diagnosed patients with histopathological confirmation of the diagnosis of breast cancer at any stage.

Exclusion Criteria:

* Patients with a prior history of other cancers.
* Patients with more than one cancer.
* Patients treated with chemotherapy or radiotherapy before initial samples collection.
* Pregnant women.
* Patients with unqualified or insufficient data.

References

Publications (0)

Data not yet available

No reference posted for this study.